期刊文献+

成人微小病变肾病血管病变与足细胞排泄的关系 被引量:3

Urine podocyte excretion in the adult-onset minimal change disease with vascular damage
原文传递
导出
摘要 目的探讨成人起病微小病变肾病(MCD)的血管病变与足细胞排泄的关系。方法入选2005年10月至2007年10月在同济大学附属第十人民医院肾脏科住院经肾穿刺活检确诊为微小病变的患者21例。根据肾穿刺病理结果,将这些患者分为有血管病变(8例)与无血管病变两组(13例),比较足细胞排泄及其与致血管病变的临床病症关系。结果伴血管病变患者尿足细胞排泄水平与肌酐比值或占尿上皮细胞中的构成比均高于无血管病变组患者(P<0.05);同时伴血管病变患者尿上皮细胞显著高于无血管病变组(P=0.018)。伴血管病变组患者体重指数(BMI)、年龄和三酰甘油均显著高于无血管病变组(P<0.05),而平均动脉压、血尿、总胆固醇、高密度脂蛋白、低密度脂蛋白及肝功能指标差异无统计学意义(P>0.05)。伴血管病变患者GFR[(83.1±13.9)mL/min对(123.0±16.9)mL/min,P=0.016]和Cystatin C[(1.12±0.16)g/L对(0.631±0.08)g/L,P=0.012]显著降低,而α1-微球蛋白、微量白蛋白、N-乙酰-β-D葡萄糖苷酶(NAG)、肌酐、尿素氮等指标和肾脏病理损伤差异无统计学意义(P>0.05)。相关性分析发现,足细胞排泄与BMI、年龄和三酰甘油无相关关系,但尿上皮细胞排泄与年龄呈正相关(P=0.014,r=0.616),年龄与血液三酰甘油呈正相关关系(P=0.01,r=0.64)。结论尿足细胞排泄与成人起病MCD的血管病变有关;年龄相关的代谢异常是成人起病MCD患者血管病变的危险因素。 Objective To investigate the relationship between vascular damage and urine podocyte excretion in adult-onset minimal change disease ( MCD ). Methods ( 1 ) Twenty-one patients with adult-onset MCD proven by renal biopsy were enrolled, 13 female and 8 male ,with an average age of 41 years. (2)These patients were divided into two groups, with( n = 8 )or without( n = 13 )vascular damages, based on their renal biopsy findings. The clinical indexes of these patients were observed and analyzed. ( 3 ) Urine podocyte excretion level was calculated by the counting from urinary sediment smear. Results ( 1 ) The MCD patients with vascular damages had a higher level of urinary podoeyte/urine croatinine, percentage of podoeyte in urine epithelial cells and urine epithelial cell excretion ( P 〈 0. 05 ). ( 2 ) The age, body mass index( BMI) and blood triglyceride level were significantly increased in the patients with vascular damages( P 〈 0. 05 ) , while other clinical characteristics such as blood pressure, haematuria, edema, liver function and blood cholesterol, HDL and LDL levels had no significant differenee(P 〉 0. 05). (3)The GFR [ (83.1 ± 13.9)mL/min vs( 123 ± 16.9) mL/min,P = 0. 016] was significantly increased in the MCD patients with vascular damages, while Cystatin C decreased [ ( 1.12 ± 0. 16 ) g/L vs ( 0.631 ± 0. 08 ) g/L, P = 0. 012 ]. The changes of BUN, SCr, SCr -MG, microalbuminuria, NAG-enzyme had no significant difference between two groups. (4)The relationship between urine podocyte excretion and metabolism index such as the BMI, age, and blood triglyceride was not observed. But the positive relationship between the age and blood triglyceride level(P =0. 01 ,r=0. 64)as well as urinary epithelial cells exeretion(P=0. 014,r =0. 616) was found. Conclusion Chronic vascular damages of patients with adultonset MCD contribute to urine podocyte excretion. The age, blood triglyceride and BMI are related to vascular damages of adult-onset MCD.
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2008年第9期732-735,共4页 Chinese Journal of Practical Internal Medicine
基金 上海市自然科学基金(06ZR14161) 中国博士后基金(2004350118)
关键词 微小病变肾病 血管病变 足细胞 minimal change disease vascular damage podocyte
  • 相关文献

参考文献10

二级参考文献49

  • 1彭艾,顾勇,肖涛,胡晔时,林善锬.尿沉渣定量分析方法的评价及影响因素研究[J].上海医学,2004,27(8):556-559. 被引量:5
  • 2Chan RW, Szeto CC. Advances in the clinical laboratory assessment of urinary sediment. Clin Chim Acta,2004, 340: 67-78.
  • 3Mclenman J, Ross M, Hawkins T, et al. Urine Microscopy; Its Clinic Value. Sysmex J Intern, 1996, 6: 41-43.
  • 4Nanni-Costa A, Iannelli S, Vangelista A, et al. Flow cytometry evaluation of urinary sediment in renal transplantation. Transpl Iht, 1992, 5 (Suppl 1): S8-S12.
  • 5Lakatos J, Bodor T, Zidarics Z, et al. Data processing of digital recordings of microscopic examination of urinary sediment. Clin Chim Acta, 2000, 297: 225-237.
  • 6King C. Automated methods in urinalysis. Clin Lab Sci, 1998,11: 44-46.
  • 7Hannemann-Pohl K, Kampf SC. Automation of urine sediment examination: a comparison of the sdysmex UF-100. automated flow cytometer with routine manual diagnosis (microscopy, test strips, and bacterial culture) Clin Chem Lab Med, 1999, 37:753-764.
  • 8Dias VC, Moschopedis T, Prosser C, et al. Evaluation of the CLINITEK ATLAS for routine microscopic urinalysis. Clin Biochem, 1996, 29: 217-223.
  • 9Vogelmann SU, Nelson WJ, Myers BD, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol, 2003, 285: F40-F48.
  • 10Layfield LJ, Elsheikh TM, Fili A, et al. Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting: the Papanicolaou Society of Cytopathology Practice Guidelines Task Forc

共引文献126

同被引文献31

  • 1杨琪,汪建国,潘涛,马路,周柱亮.Synaptopodin在肾小球病变中的表达研究[J].中国组织化学与细胞化学杂志,2004,13(4):485-488. 被引量:15
  • 2李惊子,黄海长,刘颖,鄂杰.检测尿足细胞在活动性肾小球疾病中的意义[J].北京大学学报(医学版),2005,37(5):463-466. 被引量:34
  • 3朱吉莉,丁国华.蛋白尿形成相关足细胞的结构蛋白[J].国际泌尿系统杂志,2006,26(4):540-544. 被引量:6
  • 4Camici M. Urinary detection of podocyte injury. Biomed Pharmacother, 2007,61 (5) : 245 - 249.
  • 5Hara M, Yanagihara T, Takada T, et al. Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol, 1998,18( 1 ) : 35 - 41.
  • 6Hara M, Yanagihara T, Kihara I. Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron, 2001,89 (3) : 342 - 347.
  • 7Barroso S, Martinez JM, Martin MV, et al. Accuracy of indirect estimates of renal function in advanced chronic renal failure patients. Nefrologia, 2006,26 (3) : 344 - 350.
  • 8Vogelmann SU, Nelson W J, Myers BD, et al. Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Renal Physiol, 2003,285 ( 1 ) : F40 - F48.
  • 9Li B, Hartono C, Ding R, et al. Noninvasive diagnosis of renalallograft rejection by measurement of messenger RNA for per forin and granzyme B in urine. N Engl J Med,2001,344(13) 947 - 954.
  • 10Pfaffl MW. A new mathematical model for relative quantification in realtime RT- PCR. Nucleic Acids Res,2001,29(9) :c45.

引证文献3

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部